Savara, Inc. (SVRA)
5.39
+0.13
(+2.47%)
USD |
NASDAQ |
Aug 31, 16:00
5.42
+0.03
(+0.56%)
After-Hours: 20:00
Savara Total Long Term Debt (Quarterly) : 30.11M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.11M |
| March 31, 2026 | 30.07M |
| December 31, 2025 | 29.91M |
| September 30, 2025 | 29.78M |
| June 30, 2025 | 29.65M |
| March 31, 2025 | 29.52M |
| December 31, 2024 | 26.71M |
| September 30, 2024 | 26.55M |
| June 30, 2024 | 26.48M |
| March 31, 2024 | 26.42M |
| December 31, 2023 | 26.60M |
| September 30, 2023 | 26.28M |
| June 30, 2023 | 26.21M |
| March 31, 2023 | 26.14M |
| December 31, 2022 | 26.13M |
| September 30, 2022 | 26.01M |
| June 30, 2022 | 25.94M |
| March 31, 2022 | 25.81M |
| December 31, 2021 | 25.77M |
| September 30, 2021 | 25.52M |
| June 30, 2021 | 25.38M |
| March 31, 2021 | 25.24M |
| December 31, 2020 | 25.19M |
| September 30, 2020 | 25.08M |
| June 30, 2020 | 24.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 24.93M |
| December 31, 2019 | 23.41M |
| September 30, 2019 | 25.26M |
| June 30, 2019 | 25.12M |
| March 31, 2019 | 24.68M |
| December 31, 2018 | 24.57M |
| September 30, 2018 | 15.42M |
| June 30, 2018 | 15.32M |
| March 31, 2018 | 15.20M |
| December 31, 2017 | 15.34M |
| September 30, 2017 | 15.24M |
| June 30, 2017 | 15.60M |
| March 31, 2017 | 3.502M |
| December 31, 2016 | 4.469M |
| September 30, 2016 | 14.23M |
| June 30, 2016 | 14.88M |
| March 31, 2016 | 14.84M |
| December 31, 2015 | 14.62M |
| September 30, 2015 | 14.47M |
| June 30, 2015 | 0.025M |
| March 31, 2015 | 0.027M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 26.25B |
| Insmed, Inc. | 741.01M |
| United Therapeutics Corp. | 0.00 |
| Vertex Pharmaceuticals, Inc. | 1.978B |
| SELLAS Life Sciences Group, Inc. | 0.157M |